EUVIMEDEUVIMED entdecken
Crossref

(Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling

Anastasia Golovina iD, Eleonora Proia, Francesco Fiorentino iD, Maxim Yunin iD, Maria Kasatkina, Nailya Zigangirova, Anna Soloveva, Elena Sysolyatina, Svetlana Ermolaeva, Roman Novikov iD, Sergei Silonov, Sergei Pushkin und 7 weitere

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Anastasia Golovina und 18 weiteren Autor:innen. Beteiligte Einrichtung: Sirius University of Science and Technology, Olympic Avenue, 1, Sirius , Krasnodar Region 354340, Russia. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Benzoates, Cystathionine gamma-Lyase, Enzyme Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: European Commission, Sapienza Università di Roma, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic resistance is one of the most serious global health threats. Therefore, there is a need to develop antimicrobial agents with new mechanisms of action. Targeting of bacterial cystathionine γ-lyase (bCSE), an enzyme essential for bacterial survival, is a promising approach to overcome antibiotic resistance. Here, we described a series of (heteroarylmethyl)benzoic acid derivatives and evaluated their ability to inhibit bCSE or its human ortholog hCSE using known bCSE inhibitor NL2 as a lead compound. Derivatives bearing the 6-bromoindole group proved to be the most active, with IC50 values in the midmicromolar range, and highly selective for bCSE over hCSE. Furthermore, none of these compounds showed significant toxicity to HEK293T cells. The obtained data were rationalized by ligand-based and structure-based molecular modeling analyses. The most active compounds were also found to be an effective adjunct to several widely used antibacterial agents against clinically relevant antibiotic-resistant strains of such bacteria as Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The most potent compounds, 3h and 3i, also showed a promising in vitro absorption, distribution, metabolism, and excretion (ADME) profile. Finally, compound 3i manifested potentiating activity in pneumonia, sepsis, and infected-wound in vivo models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsBenzoatesCystathionine gamma-LyaseEnzyme InhibitorsModels, MolecularAnimalsHumansMiceHEK293 CellsKlebsiella pneumoniaeMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusStructure-Activity Relationship

Stichwörter der Autor:innen

MRSAantibiotic potentiatorantimicrobial resistancebCSEbiologically active moleculesindole derivativessepsis

Substanzen

Anti-Bacterial AgentsBenzoatesCystathionine gamma-LyaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Sirius University of Science and Technology, Olympic Avenue, 1, Sirius , Krasnodar Region 354340, Russia.
  • Rome Center for Molecular Design, Department of Drug Chemistry and Technologies, Sapienza University of Rome, P. le A. Moro 5 , Rome 00185, Italy.
  • Department of Drug Chemistry and Technologies, Sapienza University of Rome, P. le A. Moro 5, Rome 00185, Italy.
  • National Research Centre of Epidemiology and Microbiology named after N. F. Gamaleya, Russian Health Ministry, Gamaleya St.18 , 123098 Moscow, Russia.
  • Engelhardt Institute of Molecular Biology of the Russian Academy of Sciences, 32 Vavilov St. , Moscow 119991, Russia.
  • Laboratory of Structural Dynamics, Stability and Folding of Proteins, Institute of Cytology, Russian Academy of Sciences, 4 Tikhoretsky Avenue , St. Petersburg 194064, Russia.

ORCID-Profile: Anastasia Golovina, Francesco Fiorentino, Maxim Yunin, Roman Novikov, Milan Mladenović, Dante Rotili, Rino Ragno

Förderung

  • European Commission
  • Sapienza Università di Roma
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Golovina, A., Proia, E., Fiorentino, F., Yunin, M., Kasatkina, M., Zigangirova, N., Soloveva, A., Sysolyatina, E., Ermolaeva, S., Novikov, R., Silonov, S., Pushkin, S., Mladenović, M., Isakova, J., Belik, A., Nawrozkij, M., Rotili, D., Ragno, R., & Ivanov, R. (2024). (Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00136

Vancouver

Golovina A, Proia E, Fiorentino F, Yunin M, Kasatkina M, Zigangirova N, et al. (Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00136

BibTeX
@article{Golovina2024,
  author = {Golovina, Anastasia and Proia, Eleonora and Fiorentino, Francesco and Yunin, Maxim and Kasatkina, Maria and Zigangirova, Nailya and Soloveva, Anna and Sysolyatina, Elena and Ermolaeva, Svetlana and Novikov, Roman and Silonov, Sergei and Pushkin, Sergei and Mladenović, Milan and Isakova, Julia and Belik, Albina and Nawrozkij, Maxim and Rotili, Dante and Ragno, Rino and Ivanov, Roman},
  title = {(Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00136}
}
Kostenlos starten →